Virtus ETF Advisers’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-16,790
Closed -$57.3K 477
2024
Q3
$57.3K Buy
16,790
+301
+2% +$1.31K 0.03% 439
2024
Q2
$77K Buy
16,489
+8,499
+106% +$47.9K 0.04% 421
2024
Q1
$59.3K Sell
7,990
-551
-6% -$4.58K 0.03% 415
2023
Q4
$86.5K Sell
8,541
-373
-4% -$3.27K 0.05% 410
2023
Q3
$69.5K Sell
8,914
-891
-9% -$7.64K 0.04% 387
2023
Q2
$80.7K Buy
9,805
+36
+0.4% +$314 0.05% 429
2023
Q1
$70.8K Sell
9,769
-3,751
-28% -$33.3K 0.04% 402
2022
Q4
$120K Buy
13,520
+3,080
+30% +$33.8K 0.06% 417
2022
Q3
$128K Buy
10,440
+70
+0.7% +$1.09K 0.05% 382
2022
Q2
$123K Buy
10,370
+4,945
+91% +$66.3K 0.05% 376
2022
Q1
$103K Sell
5,425
-315
-5% -$5.86K 0.05% 299
2021
Q4
$152K Buy
5,740
+222
+4% +$7.64K 0.06% 343
2021
Q3
$227K Sell
5,518
-288
-5% -$15.8K 0.1% 236
2021
Q2
$329K Buy
5,806
+922
+19% +$34.1K 0.14% 200
2021
Q1
$205K Buy
4,884
+86
+2% +$4.9K 0.09% 325
2020
Q4
$336K Sell
4,798
-6,619
-58% -$272K 0.14% 180
2020
Q3
$320K Sell
11,417
-1,570
-12% -$51.1K 0.17% 206
2020
Q2
$384K Buy
+12,987
New +$339K 0.18% 216

Other funds holding EDIT

Virtus ETF Advisers's EDIT Position: Q4 2024 in Review

Virtus ETF Advisers sold out of Editas Medicine (EDIT) in Q4 2024, closing a stake of 16,790 shares — an estimated $57.3K sold.

Virtus ETF Advisers first reported a position in EDIT in Q2 2020 and held it in 18 quarters. The position peaked at $384K in Q2 2020. 206 funds tracked by Wall St. Rank hold EDIT as of Q4 2024.

  • Virtus ETF Advisers reported no remaining Editas Medicine position as of Q4 2024 after selling out during the quarter.
  • Virtus ETF Advisers sold 16,790 Editas Medicine shares in Q4 2024, an estimated $57.3K.
  • Virtus ETF Advisers first reported a position in Editas Medicine in Q2 2020 and held it in 18 quarters.
  • Virtus ETF Advisers's Editas Medicine position peaked at $384K in Q2 2020.
  • 206 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2024.

Based on Virtus ETF Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.